1-14 of 14
Bryon D. Johnson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cytogenetic Abnormalities Following CAR T Cell Therapy for B-Cell Malignancies

Na Hyun Kim, Fatima Khamissi, Kathleen Bone, Nathan Kopp, Walter Longo, Bryon D. Johnson, Tyce Kearl, Peiman Hematti, Mehdi Hamadani, Timothy S. Fenske, Nirav N. Shah
Journal: Blood
Blood (2024) 144 (Supplement 1): 3459.
https://doi.org/10.1182/blood-2024-205752
Published: 2024
Journal Articles

Phase 1 Study of Trispecific Anti-CD20, Anti-CD19, Anti-CD22 (CAR20.19.22) T Cells for Relapsed, Refractory B-Cell Malignancies

Nirav N. Shah, Aniko Szabo, Tyce Kearl, Dina Schneider, Walter Longo, Bryon D. Johnson, Peiman Hematti, Mehdi Hamadani, Timothy S. Fenske
Journal: Blood
Blood (2024) 144 (Supplement 1): 3448.
https://doi.org/10.1182/blood-2024-200899
Published: 2024
Journal Articles

Treatment of Refractory Adenovirus (ADV) Infections Using Adv-Specific Cytotoxic T-Lymphocytes (CTLs) in Children, Adolescents and Young Adults (CAYA) Post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), Solid Organ Transplantation (SOT), or with Primary Immunodeficiency (PID)

Edo Schaefer, Christine Vu, Allyson Flower, Janet Ayello, Yaya Chu, Carmella Van De Ven, Elizabeth Mintzer, Lauren Harrison, Erin Morris, Yongping Wang, Shalini Shenoy, Dean Anthony Lee, Rolla ABU-Arja, Bryon D. Johnson, Michael R Verneris, Christopher C Dvorak, Julia Chu, Kenneth R. Cooke, Julie-An Talano, Nancy Bunin, Mitchell S. Cairo
Journal: Blood
Blood (2023) 142 (Supplement 1): 4836.
https://doi.org/10.1182/blood-2023-188013
Published: 2023
Journal Articles

Adaptive Manufacturing of LV20.19 CAR T-Cells for Relapsed, Refractory Mantle Cell Lymphoma

Nirav N. Shah, Fateeha Furqan, Aniko Szabo, Tyce Kearl, Anthony Zamora, Jessica Neumann, Parameswaran N. Hari, Dina Schneider, Walter Longo, Peiman Hematti, Bryon D. Johnson, Mehdi Hamadani, Timothy S. Fenske
Journal: Blood
Blood (2023) 142 (Supplement 1): 1024.
https://doi.org/10.1182/blood-2023-173954
Published: 2023
Journal Articles

Gene Therapy Expressing Platelet-Derived Factor VIII for Correction of Hemophilia Α with a History of Inhibitors

David A. Wilcox, Myriam Armant, Lynn Malec, Qizhen Shi, Bryon D. Johnson, Huiqing Xu, Lily M. Du, Lisa J. Duffy, Frederic D. Bushman, James H. Jerkins, Peiman Hematti, Ruta Brazauskas, Shawn M. Jobe, Parameswaran N. Hari, Mary Eapen
Journal: Blood
Blood (2023) 142 (Supplement 1): 2249.
https://doi.org/10.1182/blood-2023-172845
Published: 2023
Journal Articles

Dual Targeting of Slamf-7 and CD38 in Mulitple Myeloma (MM): A Phase II Study of Isatuximab, Elotuzumab, Pomalidomide and Dexamethasone (Isa-EloPD) in Relapsed and/or Refractory MM (RRMM)

Binod Dhakal, Meera Mohan, Ravi Narra, Katie Palen, Aniko Szabo, Tyce Kearl, Gayathri Ravi, Susan Bal, Bryon D. Johnson, Marcelo Pasquini, Anita D'Souza, Parameswaran N. Hari, Luciano Costa
Journal: Blood
Blood (2023) 142 (Supplement 1): 3379.
https://doi.org/10.1182/blood-2023-181266
Published: 2023
Journal Articles

Exciting new murine model of cGVHD

Bryon D. Johnson
Journal: Blood
Blood (2012) 119 (6): 1331–1332.
https://doi.org/10.1182/blood-2011-12-393496
Published: 2012
Journal Articles

Depletion of CD25 + T cells from hematopoietic stem cell grafts increases posttransplantation vaccine-induced immunity to neuroblastoma

Weiqing Jing, Xiaocai Yan, William H. D. Hallett, Jill A. Gershan, Bryon D. Johnson
Journal: Blood
Blood (2011) 117 (25): 6952–6962.
https://doi.org/10.1182/blood-2010-12-326108
Published: 2011
Includes: Supplemental data
Journal Articles

Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory

Weiqing Jing, Jill A. Gershan, Bryon D. Johnson
Journal: Blood
Blood (2009) 113 (18): 4449–4457.
https://doi.org/10.1182/blood-2008-11-190827
Published: 2009
Includes: Supplemental data
Journal Articles

Vaccine-Induced Anti-Neuroblastoma Immunity Early after HSCT Arises in the Presence of Foxp3 + CD25 + CD4 + T Cells.

Weiqing Jing, PhD, Rimas J. Orentas, Ph.D, Bryon D. Johnson, Ph.D
Journal: Blood
Blood (2006) 108 (11): 3692.
https://doi.org/10.1182/blood.V108.11.3692.3692
Published: 2006
Journal Articles

Induction of Tumor Immunity Early after Syngeneic Bone Marrow Transplantation (BMT) by Transient Transfection of Mouse Neuroblastoma with Plasmid DNA Vectors Encoding a Panel of Immune Stimulatory Molecules.

Weiqing Jing, Rimas J. Orentas, Bryon D. Johnson
Journal: Blood
Blood (2005) 106 (11): 1308.
https://doi.org/10.1182/blood.V106.11.1308.1308
Published: 2005
Journal Articles

Therapeutic expression of the platelet-specific integrin, αIIbβ3, in a murine model for Glanzmann thrombasthenia

Juan Fang, Kairbaan Hodivala-Dilke, Bryon D. Johnson, Lily M. Du, Richard O. Hynes, Gilbert C. White, II, David A. Wilcox
Journal: Blood
Blood (2005) 106 (8): 2671–2679.
https://doi.org/10.1182/blood-2004-12-4619
Published: 2005
Journal Articles

Murine Platelets Expressing a Polymorphism of Integrin β3 Associated with Acute Coronary Thrombosis in Humans.

David A. Wilcox, PhD, Juan Fang, MD, Bryon D. Johnson, PhD
Journal: Blood
Blood (2004) 104 (11): 3896.
https://doi.org/10.1182/blood.V104.11.3896.3896
Published: 2004
Journal Articles

CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance

Michael D. Rosenblum, Edit Olasz, Jeffery E. Woodliff, Bryon D. Johnson, Marja C. Konkol, Kimberly A. Gerber, Rimas J. Orentas, Gordon Sandford, Robert L. Truitt
Journal: Blood
Blood (2004) 103 (7): 2691–2698.
https://doi.org/10.1182/blood-2003-09-3184
Published: 2004